Archive - September 2021
Glenmark to launch Ryaltris® in 13 UK and EU countries
AZ buys Caelum Biosciences for $500m
Positive data for Lyme disease booster vaccine
Engineering Angles: A flexible future
ABPI: UK’s clinical research enduring slow recovery
GSK’s ViiV Healthcare agrees new deal with Shionogi to develop promising HIV drugs
Sanofi refocuses COVID-19 efforts away from mRNA
Rolling submission granted for Biogen/Eisai’s next Alzheimer’s antibody